POLI, MICHELA
POLI, MICHELA
Istituto di Fisiologia Clinica - IFC
Long-term prognostic impact of fasting plasma glucose and myocardial flow reserve beyond other risk factors and heart disease phenotypes
2024 Filidei, Elena; Caselli, Chiara; Menichetti, Luca; Poli, Michela; Petroni, Debora; Guiducci, Letizia; Sorace, Oreste; Pisani, Patrizia; Pardini, Silvia; Bonora, Danilo; Giorgetti, Assuero; Gimelli, Alessia; Neglia, Danilo
Risk Management in Good Manufacturing Practice (GMP) Radiopharmaceutical Preparations
2024 Poli, Michela; Quaglierini, Mauro; Zega, Alessandro; Pardini, Silvia; Telleschi, Mauro; Iervasi, Giorgio; Guiducci, Letizia
Risk Assessment in Pet Radiopharmaceuticals Production: Planning the Implementation of a Production Line Compliant With GMP Regulation
2022 Poli, Michela; Cornolti, Davide; Iervasi, Giorgio; Pardini, Silvia; Quaglierini, Mauro; Zega, Alessandro; Petroni, Debora
HOW DOES IT WORK A QUALITY/PERFORMANCE MANAGEMENT SYSTEM IN A BIOMEDICAL RESEARCH INSTITUTION?: LIGHTS AND SHADOWS
2021 Poli, M.; Bianchini, E.; Cornolti, D.; Pardini, S.; Pisano, E.; Simi, E.; Tedeschi, L.; Iervasi, G.
Reply to the Letter-to-the Editor of C. Lemaire and A. Luxen regarding the review "Historical and radiopharmaceutical relevance of [18F]FDG" Journal of Radioanalytical and Nuclear Chemistry (2020) 323:1017-1031, https://doi.org/10.1007/s10967-020-07013-y
2021 Petroni, D; Menichetti, L; Poli, M
Historical and radiopharmaceutical relevance of [18F]FDG
2020 Petroni, D.; Menichetti, L.; Poli, M.
Hystorical and Radiopharmaceutical Relevance of [18F]FDG
2020 Petroni, D; Menichetti, L; Poli, M
HOW AND WHY TO IMPLEMENT A PERFORMANCE MANAGEMENT SYSTEM IN PUBLIC RESEARCH INSTITUTIONS: THE APPROACH AND THE EXPERIENCE OF A LARGE MULTIDISCIPLINARY ITALIAN CENTRE
2018 Poli, Michela; Cornolti, Davide; Pardini, Silvia; Iervasi, Giorgio
The 4A's improvement approach: a case study based on UNI EN ISO 9001:2008
2014 Poli, Michela; Pardini, Silvia; Passarelli, Ilaria; Citti, Ilaria; Cornolti, Davide; Picano, Eugenio
The role of quality management system in the monitoring and continuous improvement of GMP-regulated short-lived radiopharmaceutical manufacture
2014 Poli, M.; Petroni, D.; Berton, A.; Campani, E.; Felicini, C.; Pardini, S.; Menichetti, L.; Salvadori, P. A.
Implementation of a quality assurance system according to GMP and ISO 9001:2008 standard for radiopharmaceutical production in a public research centre
2012 Michela Poli; Debora Petroni; Silvia Pardini; Piero A. Salvadori; Luca Menichetti
Implementation of Good Manufacturing Practice in small-volume production of [18F]FDG: a case report of performance measurements
2012 Petroni, D; Poli, M; Campisi, L; A Salvadori, P; Menichetti, L
Synthesis of 11C-Labeled Sodium 2-[O-[(2, 6-Dichlorophenyl)-Amino] Phenyl] Acetate ([ 11C] Diclofenac Sodium) for PET Studies
2003 Petroni, D; Menichetti, L; Riva, A; Pisani, P; Sorace, O; Poli, M; Vanasia, M; Salvadori, Piero; P,
Synthesis of 11C-labeled sodium 2-[o-[(2,6-dichlorophenyl)amino]phenyl]acetate ([11C]Diclofenac Sodium) for PET studies
2003 P.A. Salvadori; D. Petroni; L. Menichetti; A. Riva; P. Pisani; O. Sorace; M. Poli; M. Vanasia
64-Copper Azamacrocyclic Complexes: Synthesis and Preliminary Results of in vivo Biodistribution
2000 D. Petroni; F. Vizza; G. Capannesi; L. Di Luca; O. Sorace; L. Taddei; D. Dani; M. Poli; C.W. Oberhauser; P. Stoppioni; C. Bianchini; P.A. Salvadori
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients
2000 Gennari A;Donati S;Salvadori B;Giorgetti A;SALVADORI P.A.;Sorace O;Puccini G;Pisani P;Poli M;Dani D;Landucci E;Mariani G;Conte PF
Synthesis of Trimethylsilyl Derivatives as Precursors of Cholinergic System Radiotracers
2000 Martinelli, C; Petroni, D; Di Luca, L; Poli, M; Dani, D; Salvadori, Pa